PAMU
AVDL

Pictet Asset Management (UK)’s Avadel Pharmaceuticals AVDL Stock Holding History

Pictet Asset Management (UK)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-99,764
Closed -$902K – 1765
2021
Q1 		$902K Buy
+99,764
New +$807K ﹤0.01% 1069

Other funds holding AVDL

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Pictet Asset Management (UK)'s AVDL Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Avadel Pharmaceuticals (AVDL) in Q2 2021, closing a stake of 99,764 shares — an estimated $902K sold.

Pictet Asset Management (UK) first reported a position in AVDL in Q1 2021 and held it in 1 quarter. The position peaked at $902K in Q1 2021. 80 funds tracked by Wall St. Rank hold AVDL as of Q2 2021.

  • Pictet Asset Management (UK) reported no remaining Avadel Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 99,764 Avadel Pharmaceuticals shares in Q2 2021, an estimated $902K.
  • Pictet Asset Management (UK) first reported a position in Avadel Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Pictet Asset Management (UK)'s Avadel Pharmaceuticals position peaked at $902K in Q1 2021.
  • 80 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.